Synthetic DNA manufacturing could enter a new era as Daniel Arlow, the first-time founder of the new startup Ansa Biotechnologies, brings a faster and more accurate process for making DNA.
Currently, Ansa is also offering synthesis as a service rather than just selling bioprinters, that enables any researcher or scientists to manufacture their own synthetic DNA.
Arlow said that the reason why they're developing their business as a DNA synthesis service is to oppose printer making. He explained that the service allows the company to properly examine the synthetic DNA orders for biosecurity before manufacturing them.
The researcher added that other companies such as Nuclera (a Cambridge, UK-based company) and DNA Script (a France-based company) are directly selling bioprinters to research labs.
Right now, Arlow's company hasn't shipped any of their DNA products yet. However, it will soon be taking orders to start competing in the market. He added that the faster they can "crank" out the DNA, the better for his company. Arlow explained that Ansa is bad at engineering biology because it spends an extended period building a new design. Once they can make more models, the better Ansa will identify what process works and doesn't work, said Arlow.
This article is owned by TechTimes,
Written by: Giuliano de Leon.
